Experts call for safer weight loss as concerns grow over GLP-1 use - News-Medical
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
6 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 6 separate news trends connected to Drug Safety, spanning July 13, 2026 through August 31, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 45 article observations and 43 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Veterans' mental health treatments are under scrutiny as the VA evaluates its protocols.
A 19-year-old law student has died following the use of the weight loss drug Tirzepatide, prompting an official coroner's inquest.
Medical discourse on GLP-1 medications is shifting beyond weight loss as new research highlights brain mechanisms and non-weight-related health outcomes.
Six outlets report that the FDA is scrutinizing compounded GLP-1 drugs, raising concerns among doctors about potential health risks.
New research may explain why statins cause muscle pain, potentially reshaping how these common drugs are prescribed.